Results 221 to 230 of about 49,823 (359)

Permanent demand pacemaking

The Journal of Thoracic and Cardiovascular Surgery, 1974
openaire   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Incidence of Post-Procedural Conduction Disturbances and Rates of Permanent Pacemaker Implantation in Older and Newer Generations of Transcatheter Aortic Heart Valves. [PDF]

Med Sci (Basel)
Salem M, Laing P, Kühling-Thees I, Kasper W, Voran J, Seoudy H, Rangel R, Frank J, Frank D, Saad M.   +9 more
europepmc   +1 more source

Clinical Characteristics of Permanent Pacemaker and Implantable Defibrillator-Related Endocarditis: An Eleven Years Experience (1996–2006) [PDF]

, 2008
Joaquín López‐Contreras, Nuria Hernández, María Luz Gálvez, Natividad Benito, Virginia Pomar, R. Pericás, A. Cotura, Peré Domingo, M. Gurguí   +8 more
openalex   +1 more source

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang, Pauline Reynier, Antonios Douros, Oriana H. Y. Yu, Robert W. Platt, Kristian B. Filion   +5 more
wiley   +1 more source

Perioperative Risk Factors for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. [PDF]

Rev Cardiovasc Med
Peng X, Chen N, Li P, Zhu FH, Li M, Zhao XH, Zhang HP.   +6 more
europepmc   +1 more source

Machine learning‐based prediction of atrial fibrillation in patients with atrial high‐rate episodes

European Journal of Clinical Investigation, EarlyView.
Abstract Background Given the modest performance of available predictive models in estimating the risk of atrial fibrillation (AF) in patients with atrial high‐rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs), this study explores the potential use of machine learning (ML) algorithms in this context. Purpose To assess the
Amir Askarinejad, Tommaso Bucci, Niloofar Asgharzadeh, Zahra Amirjam, Enrico Tartaglia, Michele Rossi, Yang Chen, Yalin Zheng, Gregory Y. H. Lip, Majid Haghjoo   +9 more
wiley   +1 more source

Delayed Presentation of Pericardial Tamponade Resulting From Permanent Pacemaker Lead Perforation. [PDF]

Cureus
Prendergast M, Liebhardt D, Long B.
europepmc   +1 more source

Seven times replacement of permanent cardiac pacemaker in 33 years to maintain adequate heart rate: a case report.

, 2015
Yinglu Hao, Yanping Li, Derong Liao, Ling Yang   +3 more
openalex   +2 more sources

Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives

European Journal of Clinical Investigation, EarlyView.
Tricuspid regurgitation (TR), once seen as benign, is now recognized as a serious and increasingly prevalent condition linked to aging and better imaging. Its association with greater morbidity and mortality has shifted clinical perspectives towards early diagnosis and intervention.
Claudia Gonzalez‐Cucharero, Gemma Vilahur, Marta Saura, Rocío Hinojar, Jose L. Zamorano, Carlos Zaragoza   +5 more
wiley   +1 more source